Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome

Launched by ASSIUT UNIVERSITY · Jan 29, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at the differences in health outcomes between two groups of patients with a condition called antiphospholipid syndrome (APS). APS is a disorder that can increase the risk of blood clots. The study will compare people who have primary APS, which means they have the condition on its own, to those with secondary APS, where the condition is related to another illness. Researchers will gather information from patients at Assiut University Hospital to learn more about how these two groups are affected differently.

To participate in this study, patients must have been diagnosed with antiphospholipid syndrome at the hospital's hematology or rheumatology units. However, those with other conditions that could also increase their risk of blood clots, like certain cancers or specific deficiencies, won't be eligible. Although the trial is not yet recruiting participants, it aims to better understand APS and help improve care for those affected by it.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients diagnosed as antiphospholipid syndrome in clinical hematology or rheumatology units in internal medicine department, Assiut university hospital.
• Exclusion Criteria:
• • patients with other risk factor for thrombosis (malignancy, cocs, protein c or protein s deficiency etc